{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:25:22Z","timestamp":1793258722901,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacadv.2026.103196","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:07:26Z","timestamp":1788350846000},"page":"103196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["HFpEF-ABA Score for the Diagnosis and Prognosis of HFpEF in Outpatients With Type 2 Diabetes"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8446-7369","authenticated-orcid":false,"given":"Rafael","family":"Gonzalez-Manzanares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Anguita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivencio","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Gimeno-Orna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rodr\u00edguez-Padial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5792-2610","authenticated-orcid":false,"given":"Mar\u00eda","family":"Anguita-G\u00e1mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.103196_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJMcp2305181","article-title":"Heart failure with preserved ejection fraction","volume":"392","author":"Cannata","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103196_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12933-024-02358-0","article-title":"Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort\u2014the DIABET-IC study","volume":"23","author":"Gonzalez-Manzanares","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacadv.2026.103196_bib3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103196_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103196_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103196_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103196_bib7","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41591-024-03140-1","article-title":"An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score","volume":"30","author":"Reddy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jacadv.2026.103196_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5603\/CJ.a2023.0016","article-title":"Characteristics of women with type 2 diabetes mellitus and heart failure in Spain. The DIABET-IC study","volume":"31","author":"Rodr\u00edguez-Padial","year":"2024","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacadv.2026.103196_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/15409996251401741","article-title":"Sex differences in the diagnosis and management of heart failure among outpatients with type 2 diabetes","volume":"35","author":"Gonzalez-Manzanares","year":"2026","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jacadv.2026.103196_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2026.103196_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jacadv.2026.103196_bib12","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103196_bib13","article-title":"Use and misuse of composite endpoints in randomised clinical trials","author":"Siquier-Padilla","year":"2025","journal-title":"Heart"},{"key":"10.1016\/j.jacadv.2026.103196_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12933-025-02774-w","article-title":"Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treatment","volume":"24","author":"Gorica","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacadv.2026.103196_bib15","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.jacc.2025.03.009","article-title":"Interplay of chronic kidney disease and the effects of tirzepatide in patients with heart failure, preserved ejection fraction, and obesity: the SUMMIT trial","volume":"85","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103196_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12933-025-02708-6","article-title":"Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction","volume":"24","author":"Vranken","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacadv.2026.103196_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-025-02707-7","article-title":"Metabolic rewiring and inter-organ crosstalk in diabetic HFpEF","volume":"24","author":"Luo","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacadv.2026.103196_bib18","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103196_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12933-025-02738-0","article-title":"Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis","volume":"24","author":"Lin","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacadv.2026.103196_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12933-025-02788-4","article-title":"Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK biobank","volume":"24","author":"Bertrand","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacadv.2026.103196_bib21","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/eurheartj\/ehy268","article-title":"Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction","volume":"39","author":"Obokata","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103196_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ehf2.15059","article-title":"Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides","volume":"12","author":"Berthelot","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacadv.2026.103196_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011366","article-title":"Uncovering unrecognized heart failure with preserved ejection fraction among individuals with obesity and dyspnea","volume":"17","author":"Kosyakovsky","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacadv.2026.103196_bib24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.124.072156","article-title":"Evidence-based application of natriuretic peptides in the evaluation of chronic heart failure with preserved ejection fraction in the ambulatory outpatient setting","volume":"151","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103196_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009664","article-title":"Body mass index, natriuretic peptides, and risk of adverse outcomes in patients with heart failure and preserved ejection fraction: analysis from the TOPCAT trial","volume":"7","author":"Pandey","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2026.103196_bib26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cardfail.2023.03.029","article-title":"The influence of body mass index on clinical interpretation of established and novel biomarkers in acute heart failure","volume":"29","author":"Horiuchi","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacadv.2026.103196_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2026.103196_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacadv.2026.103196_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.125.074974","article-title":"New algorithm for estimating left ventricular filling pressure by echocardiography","author":"Lababidi","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103196_bib30","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2021-319605","article-title":"Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management","volume":"108","author":"Gevaert","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.jacadv.2026.103196_bib31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/ejhf.2601","volume":"24","author":"Guazzi","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacadv.2026.103196_bib32","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1002\/ehf2.14436","article-title":"Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction","volume":"10","author":"Lanzarone","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacadv.2026.103196_bib33","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103196_bib34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","article-title":"Heart failure with preserved ejection fraction: everything the clinician needs to know","volume":"403","author":"Campbell","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2026.103196_bib35","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103196_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-8587(24)00304-8","article-title":"Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial","volume":"13","author":"Davies","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacadv.2026.103196_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-025-10540-z","article-title":"Time to screen: rationale and roadmap for HFpEF screening in individuals with obesity","author":"Achten","year":"2025","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacadv.2026.103196_bib38","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.jacc.2024.08.061","article-title":"Clinical implications of pretest probability of HFpEF on outcomes in precapillary pulmonary hypertension","volume":"84","author":"Reddy","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103196_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-01537-7","article-title":"Comparison of the 2021 ESC guideline with the HFA-PEFF and H2FPEF scores in diagnosing heart failure with preserved ejection fraction","volume":"15","author":"Yoon","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacadv.2026.103196_bib40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26006174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26006174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:23:09Z","timestamp":1793215389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26006174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2772963X26006174"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103196","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HFpEF-ABA Score for the Diagnosis and Prognosis of HFpEF in Outpatients With Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103196"}}